PDS Biotechnology Corp expected to post a loss of 35 cents a share - Earnings Preview

PDS Biotechnology

04/08/2023 19:38

* PDS Biotechnology Corp  PDSB.OQ   PDSB.O  is expected
to show no
change in quarterly revenue when it reports  results on August 7
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for PDS Biotechnology
Corp is
for a loss of 35 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PDS
Biotechnology
Corp is $18​, above​ its last closing price of $5.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.31       -0.31      -0.32     Missed  -4.7
 Dec. 31 2023              -0.29      -0.67     Missed  -133.3
 Sep. 30 2022  -0.28       -0.28      -0.26     Beat    7.6​
 Jun. 30 2022  -0.28       -0.28      -0.20     Beat    29
 ​​Mar.        -0.23       -0.22      -0.32     Missed  -42.9
 31 2022                                                
 Dec. 31 2021  -0.27       -0.24      -0.22     Beat    9​
 Sep. 30 2021  -0.20       -0.20      -0.24     Missed  -17.1
 Jun. 30 2021  -0.17       -0.17      -0.03     Beat    82.8
 This summary was machine generated August 4 at 18:37 GMT.  All
figures in US dollars  unless otherwise stated